A new heterologous fibrin sealant as scaffold to recombinant human bone morphogenetic protein-2 (rhBMP-2) and natural latex proteins for the repair of tibial bone defects

被引:37
|
作者
Machado, Eduardo Gomes [1 ]
Mardegan Issa, Joao Paulo [2 ]
Tocchini de Figueiredo, Fellipe Augusto [2 ]
dos Santos, Geovane Ribeiro [1 ]
Galdeano, Ewerton Alexandre [1 ]
Alves, Mariana Carla [1 ]
Chacon, Erivelto Luis [1 ]
Ferreira Junior, Rui Seabra [3 ]
Barraviera, Benedito [3 ]
da Cunha, Marcelo Rodrigues [1 ]
机构
[1] Sch Med Jundiai, Dept Morphol & Pathol, BR-13202550 Jundiai, SP, Brazil
[2] Univ Sao Paulo, Dent Sch Ribeirao Preto, Dept Morphol Stomatol & Physiol, BR-14040904 Ribeirao Preto, SP, Brazil
[3] Sao Paulo State Univ UNESP Univ Estadual Paulista, Ctr Study Venoms & Venomous Anim CEVAP, BR-18610307 Botucatu, SP, Brazil
关键词
Fibrin; Sealant; Scaffold; BMP-2; Natural latex; Protein P-1; SNAKE-VENOM; GLUE; CELL; COMPOSITES; VIABILITY; BMP-2;
D O I
10.1016/j.acthis.2015.03.006
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Tissue engineering has special interest in bone tissue aiming at future medical applications Studies have focused on recombinant human bone morphogenetic protein-2 (rhBMP-2) and natural latex proteins due to the osteogenic properties of rhBMP-2 and the angiogenic characteristic of fraction 1 protein (P-1) extracted from the rubber tree Hevea brasiliensis. Furthermore, heterologous fibrin sealant (FS) has been shown as a promising alternative in regenerative therapies. The aim of this study was to evaluate these substances for the repair of bone defects in rats. A bone defect measuring 3 mm in diameter was created in the proximal metaphysis of the left tibia of 60 rats and was implanted with rhBMP-2 or P-1 in combination with a new heterologous FS derived from snake venom. The animals were divided into six groups: control (unfilled bone defect), rhBMP-2 (defect filled with 5 mu g rhBMP-2), P-1 (defect filled with 5 mu g P-1), FS (defect filled with 8 mu g FS), FS/rhBMP-2 (defect filled with 8 mu g FS and 5 mu g rhBMP-2), FS/P-1 (defect filled with 8 mu g FS and 5 mu g P-1). The animals were sacrificed 2 and 6 weeks after surgery. The newly formed bone projected from the margins of the original bone and exhibited trabecular morphology and a disorganized arrangement of osteocyte lacunae. Immunohistochemical analysis showed intense expression of osteocalcin in all groups. Histometric analysis revealed a significant difference in all groups after 2 weeks (p < 0.05), except for the rhBMP-2 and FS/rhBMP-2 groups (p > 0.05). A statistically significant difference (p < 0.05) was observed in all groups after 6 weeks in relation to the volume of newly formed bone in the surgical area. In conclusion, the new heterologous fibrin sealant was found to be biocompatible and the combination with rhBMP-2 showed the highest osteogenic and osteoconductive capacity for bone healing. These findings suggest a promising application of this combination in the regeneration surgery. (C) 2015 Elsevier GmbH. All rights reserved.
引用
收藏
页码:288 / 296
页数:9
相关论文
共 50 条
  • [41] Osteoclast differentiation in ectopic bone formation induced by recombinant human bone morphogenetic protein 2 (rhBMP-2)
    Kazuharu Irie
    Cansu Alpaslan
    Koichiro Takahashi
    Yukari Kondo
    Naoya Izumi
    Yasunori Sakakura
    Eichi Tsuruga
    Tamio Nakajima
    Sadakazu Ejiri
    Hidehiro Ozawa
    Toshihiko Yajima
    Journal of Bone and Mineral Metabolism, 2003, 21 : 363 - 369
  • [42] Osteoclast differentiation in ectopic bone formation induced by recombinant human bone morphogenetic protein 2 (rhBMP-2)
    Irie, K
    Alpaslan, C
    Takahashi, K
    Kondo, Y
    Izumi, N
    Sakakura, Y
    Tsuruga, E
    Nakajima, T
    Ejiri, S
    Ozawa, H
    Yajima, T
    JOURNAL OF BONE AND MINERAL METABOLISM, 2003, 21 (06) : 363 - 369
  • [43] RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN-2 AND PROTEIN-4 (RHBMP-2 AND RHBMP-4) INDUCE SEVERAL MESENCHYMAL PHENOTYPES IN CULTURE
    DIXON, KP
    MURPHY, RW
    SOUTHERLAND, SS
    YOUNG, HE
    DALTON, ML
    LUCA, PA
    FASEB JOURNAL, 1995, 9 (03): : A311 - A311
  • [44] Enhancement of recombinant human bone morphogenetic protein-2 (rhBMP-2)-induced new bone formation by concurrent treatment with parathyroid hormone and a phosphodiesterase inhibitor, pentoxifylline
    Hiroshi Horiuchi
    Naoto Saito
    Tetsuya Kinoshita
    Shinji Wakabayashi
    Takahiro Tsutsumimoto
    Satoru Otsuru
    Kunio Takaoka
    Journal of Bone and Mineral Metabolism, 2004, 22 : 329 - 334
  • [45] Enhancement of recombinant human bone morphogenetic protein-2 (rhBMP-2)-induced new bone formation by concurrent treatment with parathyroid hormone and a phosphodiesterase inhibitor, pentoxifylline
    Horiuchi, H
    Saito, N
    Kinoshita, T
    Wakabayashi, S
    Tsutsumimoto, T
    Otsuru, S
    Takaoka, K
    JOURNAL OF BONE AND MINERAL METABOLISM, 2004, 22 (04) : 329 - 334
  • [46] Recombinant human bone morphogenetic protein-2
    Shaffrey, Christopher I.
    Smith, Justin S.
    JOURNAL OF NEUROSURGERY-SPINE, 2013, 18 (02) : 109 - 110
  • [47] Antigen-free bovine cancellous bone loaded with recombinant human bone morphogenetic protein-2 for the repair of tibial bone defects in goat model
    Li, Donghai
    Deng, Liqing
    Yang, Zhouyuan
    Xie, Xiaowei
    Kang, Pengde
    Tan, Zhen
    JOURNAL OF BIOMATERIALS APPLICATIONS, 2016, 30 (09) : 1322 - 1333
  • [48] Biomolecules in tissue engineered medical products (TEMPs): a case study of Recombinant Human Bone Morphogenetic Protein-2 (rhBMP-2)
    Porter, TJ
    Rathore, S
    Rouse, J
    Denton, M
    TISSUE ENGINEERED MEDICAL PRODUCTS (TEMPS), 2004, 1452 : 150 - 171
  • [49] Sex Differences in Response to Recombinant Human Bone Morphogenetic Protein-2 (rhBMP-2) in a Rat Posterolateral Fusion Spine Model
    Goodwin, Alyssa
    Brecount, Hogan
    Kurapaty, Steven
    Inglis, Jackie
    Stock, Stuart
    Yun, Chawon
    Jeong, Soyeon
    Minardi, Silvia
    Hsu, Wellington
    Hsu, Erin
    JOURNAL OF BONE AND MINERAL RESEARCH, 2023, 38 : 301 - 302
  • [50] OSSEOUS REGENERATION IN THE RAT CALVARIUM USING NOVEL DELIVERY SYSTEMS FOR RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN-2 (RHBMP-2)
    KENLEY, R
    MARDEN, L
    TUREK, T
    JIN, L
    RON, E
    HOLLINGER, JO
    JOURNAL OF BIOMEDICAL MATERIALS RESEARCH, 1994, 28 (10): : 1139 - 1147